Key Highlights
- Shashank Srowthy assumes the role of Chief Financial Officer on 1 October 2025.
- Lokesh Chandak steps down as CFO and will serve as Senior Director – Finance & Accounting for Feminine Care across APAC, MENA, and Africa.
- Srowthy brings a decade of experience from India, Dubai, and Singapore, having led pivotal finance initiatives.
- His appointment as Executive Director requires shareholder approval and clearance under Section 196 of the Companies Act, 2013.
- The transition underscores P&G Health’s commitment to global financial acumen and operational agility in high‑growth markets.
Detailed Insights
Shashank Srowthy, a graduate of Pune University with a Bachelor’s in Electronics & Telecommunication Engineering and a Master of Management Studies from JBIMS Mumbai, joined Procter & Gamble in 2011. Over the years, he has held key finance positions across India, Dubai, and Singapore, consistently delivering strategic financial outcomes in diverse markets.
Until the forthcoming Annual General Meeting, Srowthy will serve as an Additional Director. His elevation to Executive Director is contingent upon shareholder endorsement and the requisite central government clearance under Section 196 of the Companies Act, 2013.
The leadership change is strategically aligned with P&G Health’s focus on strengthening financial oversight within the healthcare sector, enhancing operational agility, and leveraging global finance expertise to navigate high‑growth regions.
Key Concepts
- CFO (Chief Financial Officer) – The senior executive responsible for managing the company’s financial actions.
- Additional Director – A temporary board position held until formal appointment as Executive Director.
- Section 196, Companies Act, 2013 – Legal provision requiring central government approval for certain directorships.
- Operational Agility – The ability of an organization to rapidly adapt its operations to changing market conditions.
- High‑Growth Markets – Regions or sectors experiencing accelerated expansion and demand.